APA

Miura Y., Kainuma M., Jiang H., Velasco H., Vogt P. K. & Hakomori S. (20041227). Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Miura Yutaka, Kainuma Mami, Jiang Hao, Velasco Hershey, Vogt Peter K and Hakomori Senitiroh. 20041227. Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Miura Y., Kainuma M., Jiang H., Velasco H., Vogt P. K. and Hakomori S. (20041227). Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Miura Yutaka, Kainuma Mami, Jiang Hao, Velasco Hershey, Vogt Peter K and Hakomori Senitiroh. Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). : Proceedings of the National Academy of Sciences of the United States of America. 20041227.